Bio Rad Laboratories Stock Total Debt

BIO Stock

USD 278.21 7.07 2.48%

Bio Rad Laboratories fundamentals help investors to digest information that contributes to Bio Rad's financial success or failures. It also enables traders to predict the movement of Bio Stock. The fundamental analysis module provides a way to measure Bio Rad's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bio Rad stock.

Short Long Term Debt Total Total Assets

As of the 25th of April 2024, Total Debt To Capitalization is likely to drop to 0.12.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Bio Rad Laboratories Company Total Debt Analysis

Bio Rad's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

Total Debt

Bonds

+

Notes

More About Total Debt | All Equity Analysis

Current Bio Rad Total Debt

1.41 B

Most of Bio Rad's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bio Rad Laboratories is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Bio Total Debt Driver Correlations

Understanding the fundamental principles of building solid financial models for Bio Rad is extremely important. It helps to project a fair market value of Bio Stock properly, considering its historical fundamentals such as Total Debt. Since Bio Rad's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Bio Rad's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Bio Rad's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Accounts Payable	Intangible Assets	Common Stock	Long Term Debt	Good Will	Treasury Stock	Property Plant Equipment	Current Deferred Revenue	Short Term Investments	Net Tangible Assets	Capital Surpluse	Deferred Long Term Liab	Accumulated Depreciation	Long Term Debt Total	Long Term Investments	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		1.0	0.14	1.0	0.4	0.98	0.69	0.08	0.58	0.42	-0.37	0.17	-0.15	-0.8	0.67	0.42	0.62	0.99	0.82	0.98	-0.92	0.01	0.96	-0.67	0.4	0.45	0.44	-0.4
Total Stockholder Equity	1.0		0.08	1.0	0.38	0.97	0.65	0.08	0.59	0.39	-0.35	0.12	-0.18	-0.78	0.67	0.38	0.58	0.98	0.82	0.99	-0.92	-0.04	0.97	-0.67	0.41	0.43	0.4	-0.37
Net Debt	0.14	0.08		0.15	0.07	0.3	0.57	-0.13	-0.45	0.38	-0.07	0.96	0.17	-0.64	-0.13	0.75	0.82	0.2	0.14	0.12	-0.13	0.94	-0.06	-0.18	-0.24	0.45	0.8	-0.72
Retained Earnings	1.0	1.0	0.15		0.34	0.97	0.67	0.09	0.53	0.39	-0.31	0.18	-0.21	-0.82	0.62	0.44	0.63	0.99	0.81	0.99	-0.9	0.04	0.96	-0.66	0.41	0.46	0.45	-0.42
Net Receivables	0.4	0.38	0.07	0.34		0.46	0.68	0.02	0.56	0.76	-0.88	0.21	0.62	-0.26	0.81	0.0	0.29	0.31	0.59	0.26	-0.52	-0.08	0.33	-0.34	-0.03	0.27	0.3	0.12
Total Liab	0.98	0.97	0.3	0.97	0.46		0.81	0.09	0.5	0.52	-0.45	0.35	-0.05	-0.87	0.64	0.5	0.74	0.97	0.82	0.95	-0.91	0.16	0.9	-0.65	0.37	0.53	0.55	-0.48
Total Current Assets	0.69	0.65	0.57	0.67	0.68	0.81		0.1	0.35	0.64	-0.73	0.64	0.3	-0.78	0.59	0.59	0.84	0.68	0.74	0.6	-0.78	0.38	0.49	-0.57	0.22	0.62	0.67	-0.56
Short Term Debt	0.08	0.08	-0.13	0.09	0.02	0.09	0.1		0.11	-0.22	-0.07	-0.27	-0.29	0.01	0.1	0.01	0.03	0.08	0.23	0.07	-0.2	-0.32	0.08	0.24	0.63	0.16	-0.18	0.0
Accounts Payable	0.58	0.59	-0.45	0.53	0.56	0.5	0.35	0.11		0.15	-0.51	-0.35	0.07	-0.17	0.77	-0.3	0.04	0.47	0.66	0.49	-0.7	-0.52	0.61	-0.56	0.18	0.08	-0.07	0.29
Intangible Assets	0.42	0.39	0.38	0.39	0.76	0.52	0.64	-0.22	0.15		-0.64	0.52	0.67	-0.44	0.52	0.21	0.47	0.36	0.33	0.32	-0.33	0.31	0.33	-0.1	-0.12	0.29	0.53	-0.1
Common Stock	-0.37	-0.35	-0.07	-0.31	-0.88	-0.45	-0.73	-0.07	-0.51	-0.64		-0.22	-0.65	0.18	-0.74	-0.1	-0.26	-0.3	-0.48	-0.24	0.5	0.13	-0.22	0.29	-0.1	-0.15	-0.11	0.1
Long Term Debt	0.17	0.12	0.96	0.18	0.21	0.35	0.64	-0.27	-0.35	0.52	-0.22		0.3	-0.64	-0.06	0.67	0.82	0.22	0.15	0.13	-0.16	0.94	-0.03	-0.24	-0.28	0.48	0.82	-0.64
Good Will	-0.15	-0.18	0.17	-0.21	0.62	-0.05	0.3	-0.29	0.07	0.67	-0.65	0.3		0.17	0.3	-0.04	0.02	-0.21	-0.1	-0.26	0.11	0.1	-0.27	0.12	-0.38	-0.17	0.05	0.08
Treasury Stock	-0.8	-0.78	-0.64	-0.82	-0.26	-0.87	-0.78	0.01	-0.17	-0.44	0.18	-0.64	0.17		-0.32	-0.68	-0.93	-0.84	-0.71	-0.79	0.76	-0.55	-0.7	0.62	-0.22	-0.74	-0.85	0.63
Property Plant Equipment	0.67	0.67	-0.13	0.62	0.81	0.64	0.59	0.1	0.77	0.52	-0.74	-0.06	0.3	-0.32		0.05	0.25	0.59	0.78	0.58	-0.73	-0.33	0.65	-0.55	0.09	0.08	0.14	0.04
Current Deferred Revenue	0.42	0.38	0.75	0.44	0.0	0.5	0.59	0.01	-0.3	0.21	-0.1	0.67	-0.04	-0.68	0.05		0.72	0.53	0.39	0.47	-0.36	0.58	0.23	-0.37	0.2	0.45	0.59	-0.95
Short Term Investments	0.62	0.58	0.82	0.63	0.29	0.74	0.84	0.03	0.04	0.47	-0.26	0.82	0.02	-0.93	0.25	0.72		0.65	0.6	0.58	-0.64	0.72	0.45	-0.53	0.08	0.71	0.89	-0.69
Net Tangible Assets	0.99	0.98	0.2	0.99	0.31	0.97	0.68	0.08	0.47	0.36	-0.3	0.22	-0.21	-0.84	0.59	0.53	0.65		0.81	0.99	-0.89	0.07	0.94	-0.68	0.43	0.48	0.47	-0.51
Capital Surpluse	0.82	0.82	0.14	0.81	0.59	0.82	0.74	0.23	0.66	0.33	-0.48	0.15	-0.1	-0.71	0.78	0.39	0.6	0.81		0.78	-0.93	-0.05	0.78	-0.77	0.34	0.57	0.5	-0.28
Deferred Long Term Liab	0.98	0.99	0.12	0.99	0.26	0.95	0.6	0.07	0.49	0.32	-0.24	0.13	-0.26	-0.79	0.58	0.47	0.58	0.99	0.78		-0.87	0.0	0.96	-0.65	0.43	0.42	0.41	-0.45
Accumulated Depreciation	-0.92	-0.92	-0.13	-0.9	-0.52	-0.91	-0.78	-0.2	-0.7	-0.33	0.5	-0.16	0.11	0.76	-0.73	-0.36	-0.64	-0.89	-0.93	-0.87		0.04	-0.84	0.78	-0.4	-0.54	-0.44	0.35
Long Term Debt Total	0.01	-0.04	0.94	0.04	-0.08	0.16	0.38	-0.32	-0.52	0.31	0.13	0.94	0.1	-0.55	-0.33	0.58	0.72	0.07	-0.05	0.0	0.04		-0.13	-0.12	-0.36	0.42	0.79	-0.56
Long Term Investments	0.96	0.97	-0.06	0.96	0.33	0.9	0.49	0.08	0.61	0.33	-0.22	-0.03	-0.27	-0.7	0.65	0.23	0.45	0.94	0.78	0.96	-0.84	-0.13		-0.61	0.39	0.37	0.34	-0.19
Short Long Term Debt	-0.67	-0.67	-0.18	-0.66	-0.34	-0.65	-0.57	0.24	-0.56	-0.1	0.29	-0.24	0.12	0.62	-0.55	-0.37	-0.53	-0.68	-0.77	-0.65	0.78	-0.12	-0.61		-0.01	-0.39	-0.45	0.35
Cash And Equivalents	0.4	0.41	-0.24	0.41	-0.03	0.37	0.22	0.63	0.18	-0.12	-0.1	-0.28	-0.38	-0.22	0.09	0.2	0.08	0.43	0.34	0.43	-0.4	-0.36	0.39	-0.01		0.46	-0.1	-0.23
Net Invested Capital	0.45	0.43	0.45	0.46	0.27	0.53	0.62	0.16	0.08	0.29	-0.15	0.48	-0.17	-0.74	0.08	0.45	0.71	0.48	0.57	0.42	-0.54	0.42	0.37	-0.39	0.46		0.76	-0.37
Net Working Capital	0.44	0.4	0.8	0.45	0.3	0.55	0.67	-0.18	-0.07	0.53	-0.11	0.82	0.05	-0.85	0.14	0.59	0.89	0.47	0.5	0.41	-0.44	0.79	0.34	-0.45	-0.1	0.76		-0.47
Capital Stock	-0.4	-0.37	-0.72	-0.42	0.12	-0.48	-0.56	0.0	0.29	-0.1	0.1	-0.64	0.08	0.63	0.04	-0.95	-0.69	-0.51	-0.28	-0.45	0.35	-0.56	-0.19	0.35	-0.23	-0.37	-0.47

Click cells to compare fundamentals

Bio Total Debt Historical Pattern

Today, most investors in Bio Rad Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Bio Rad's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total debt growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Bio Rad total debt as a starting point in their analysis.

Bio Rad Total Debt

Timeline

In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.

Competition

Predict Bio Rad

Short Long Term Debt Total Over Time

Bio Short Long Term Debt Total

Short Long Term Debt Total

1.48 Billion

At this time, Bio Rad's Short and Long Term Debt Total is very stable compared to the past year.

Based on the latest financial disclosure, Bio Rad Laboratories has a Total Debt of 1.41 B. This is 48.9% lower than that of the Life Sciences Tools & Services sector and 19.53% lower than that of the Health Care industry. The total debt for all United States stocks is 73.56% higher than that of the company.

Bio Total Debt Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bio Rad's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bio Rad could also be used in its relative valuation, which is a method of valuing Bio Rad by comparing valuation metrics of similar companies.

Bio Rad is currently under evaluation in total debt category among related companies.

Bio Rad ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Bio Rad's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Bio Rad's managers, analysts, and investors.

Environment Score

Governance Score

Social Score

Bio Rad Institutional Holders

Institutional Holdings refers to the ownership stake in Bio Rad that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Bio Rad's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Bio Rad's value.

		Shares
Thompson, Siegel & Walmsley Llc	2023-12-31	348.5 K
Massachusetts Financial Services Company	2023-12-31	322.3 K
Goldman Sachs Group Inc	2023-12-31	288.7 K
Hound Partners, Llc	2023-12-31	261.7 K
Northern Trust Corp	2023-12-31	252.4 K
Morgan Stanley - Brokerage Accounts	2023-12-31	250.1 K
Westfield Capital Management Company, Lp	2023-12-31	247.2 K
Parnassus Investments Llc	2023-12-31	237.8 K
Norges Bank	2023-12-31	226.5 K
Vanguard Group Inc	2023-12-31	2.4 M
Blackrock Inc	2023-12-31	1.5 M

Bio Fundamentals

	Return On Equity	-0.0694
	Return On Asset	0.0177
	Profit Margin	(0.24) %
	Operating Margin	0.14 %
	Current Valuation	7.79 B
	Shares Outstanding	23.42 M
	Shares Owned By Insiders	15.23 %
	Shares Owned By Institutions	81.70 %
	Number Of Shares Shorted	564.75 K
	Price To Earning	2.90 X
	Price To Book	0.98 X
	Price To Sales	3.28 X
	Revenue	2.67 B
	Gross Profit	1.57 B
	EBITDA	576.2 M
	Net Income	(637.32 M)
	Cash And Equivalents	434.21 M
	Cash Per Share	62.03 X
	Total Debt	1.41 B
	Debt To Equity	0.16 %
	Current Ratio	5.50 X
	Book Value Per Share	306.51 X
	Cash Flow From Operations	374.94 M
	Short Ratio	3.22 X
	Earnings Per Share	(21.82) X
	Price To Earnings To Growth	1.19 X
	Target Price	409.8
	Number Of Employees	8.03 K
	Beta	0.88
	Market Capitalization	8.11 B
	Total Asset	12.3 B
	Retained Earnings	9.26 B
	Working Capital	2.53 B
	Current Asset	466.61 M
	Current Liabilities	208.93 M
	Net Asset	12.3 B

About Bio Rad Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Bio Rad Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bio Rad using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bio Rad Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Pair Trading with Bio Rad

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bio Rad position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Rad will appreciate offsetting losses from the drop in the long position's value.

Moving against Bio Stock

0.75	ELYM	Eliem Therapeutics	Pair Corr
0.57	ACB	Aurora Cannabis Trending	Pair Corr

The ability to find closely correlated positions to Bio Rad could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bio Rad when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bio Rad - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bio Rad Laboratories to buy it.

The correlation of Bio Rad is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bio Rad moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bio Rad Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Bio Rad can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Bio Rad Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Rad's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Rad Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Rad Laboratories Stock:

How To Invest In Bio

Details

Is Bio Stock a good investment?

Details

What is Bio Rad's Net Worth?

Details

Largest Life Sciences Tools & Services Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Bio Rad Piotroski F Score and Bio Rad Altman Z Score analysis.

You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Complementary Tools for Bio Stock analysis

When running Bio Rad's price analysis, check to measure Bio Rad's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Rad is operating at the current time. Most of Bio Rad's value examination focuses on studying past and present price action to predict the probability of Bio Rad's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Rad's price. Additionally, you may evaluate how the addition of Bio Rad to your portfolios can decrease your overall portfolio volatility.

	Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges
	Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
	Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios
	FinTech Suite Use AI to screen and filter profitable investment opportunities
	Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon
	USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA
	Commodity Directory Find actively traded commodities issued by global exchanges
	Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios
	Global Correlations Find global opportunities by holding instruments from different markets
	Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences
	Portfolio Anywhere Track or share privately all of your investments from the convenience of any device

Is Bio Rad's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Rad. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Rad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.56)

Earnings Share

(21.82)

Revenue Per Share

91.453

Quarterly Revenue Growth

(0.07)

Return On Assets

0.0177

The market value of Bio Rad Laboratories is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Rad's value that differs from its market value or its book value, called intrinsic value, which is Bio Rad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Rad's market value can be influenced by many factors that don't directly affect Bio Rad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Bio Rad's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Rad is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Rad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Bio Rad Laboratories Stock Total Debt

Bio Rad Laboratories Company Total Debt Analysis

Total Debt

Bonds

+

Notes

Current Bio Rad Total Debt

Bio Total Debt Driver Correlations

Bio Total Debt Historical Pattern

Bio Short Long Term Debt Total

Short Long Term Debt Total

1.48 Billion

Bio Total Debt Peer Comparison

Bio Rad ESG Sustainability

Bio Rad Institutional Holders

Bio Fundamentals

About Bio Rad Fundamental Analysis

Pair Trading with Bio Rad

Moving against Bio Stock

Complementary Tools for Bio Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY